Zobrazeno 1 - 10
of 56
pro vyhledávání: '"Jindřich, Fínek"'
Autor:
Ondřej Fiala, Michaela Tkadlecová, Kristýna Pivovarčíková, Jan Baxa, Petr Stránský, Dominika Šiková, Milan Hora, Jindřich Fínek
Publikováno v:
Case Reports in Oncology, Vol 17, Iss 1, Pp 921-927 (2024)
Introduction: Combined immuno-oncology (IO) regimens are the cornerstone of the current front-line systemic therapy for metastatic renal cell carcinoma (mRCC). Despite the fact that combined IO regimens show high efficacy, they are often accompanied
Externí odkaz:
https://doaj.org/article/a58094ae305241c5b82579073dce00d2
Autor:
Ondřej Fiala, Petr Hošek, Hana Korunková, Milan Hora, Jiří Kolář, Ondřej Šorejs, Ondřej Topolčan, Jan Filipovský, Václav Liška, Matteo Santoni, Sebastiano Buti, Jindřich Fínek
Publikováno v:
Cancer Medicine, Vol 13, Iss 1, Pp n/a-n/a (2024)
Abstract Background The introduction of novel hormonal therapies represented by enzalutamide (ENZ) and abiraterone acetate (ABI) has reached a great progress in the treatment of metastatic castration‐resistant prostate cancer (mCRPC). The majority
Externí odkaz:
https://doaj.org/article/5f8e63dc27574f2fb1ca38cbf6ec024b
Autor:
Milan Hora, Tomas Buchler, Jan Filipovský, Pavel Ostasov, Ivan Trávníček, Barbora Bendová, Jan Šustr, Jindřich Fínek, Aneta Rozsypalova, Ondřej Šorejs, Ondřej Fiala
Publikováno v:
Targeted Oncology. 16:643-652
Patients with metastatic renal cell carcinoma (mRCC) are often elderly and have various comorbidities, including cardiovascular diseases. Although these patients have extensive co-exposure to targeted therapy and cardiovascular drugs, the impact of t
Autor:
Petra Kovářová, Ondřej Daum, Jan Baxa, Michal Krcma, Emília Sukovská, Radovan Vojtíšek, Jindřich Fínek
Publikováno v:
Strahlentherapie und Onkologie. 197:847-853
Carcinoma showing thymus-like elements (CASTLE) is an extremely rare malignant tumor of the thyroid gland and soft tissues of the neck with favorable prognosis. Histological features of the CASTLE are similar to thymic carcinoma, and it is assumed th
Autor:
Marika Kylarová, Denisa Kacerovska, Jan Baxa, Radovan Vojtíšek, Emília Sukovská, Jindřich Fínek, Barbora Divišová
Publikováno v:
Rep Pract Oncol Radiother
Lymphangiosarcoma, or Stewart-Treves Syndrome (STS), is a very rare skin angiosarcoma with poor prognosis, which usually affects the upper limbs of patients who underwent breast cancer surgery, including axillary dissection followed by radiotherapy (
Autor:
Pavel, Dundr, David, Cibula, Martin, Doležel, Pavel, Fabian, Jindřich, Fínek, Tomáš, Jirásek, Radoslav, Matěj, Luboš, Petruželka, Lukáš, Rob, Aleš, Ryška, Marián, Švajdler, Vít, Weinberger, Michal, Zikán
Publikováno v:
Ceskoslovenska patologie. 57(3)
Molecular classification of endometrial carcinoma is becoming an important part of the diagnostic process with direct therapeutic implications. Recent international guidelines, including the joint ESGO-ESTRO-ESP recommendation, include the molecular
Autor:
Pavel, Dundr, Radoslav, Matěj, Aleš, Ryška, Jana, Prausová, Jindřich, Fínek, Luboš, Petruželka, Ivana, Stružinská
Publikováno v:
Ceskoslovenska patologie. 57(3)
Molecular testing of tumor tissue for the detection of somatic aberrations using NGS is increasingly gaining significance in routine practice. The technical aspects of testing are standardized and currently do not pose a problem. However, the situati
Autor:
Radovan Vojtíšek, Petr Hošek, Emília Sukovská, Petra Kovářová, Jan Baxa, Jiří Ferda, Jindřich Fínek
Publikováno v:
Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]. 198(9)
Image-guided adaptive brachytherapy (IGABT) is currently state of the art in the comprehensive treatment of patients with cervical cancer. Here, we report mature clinical data regarding IGABT of cervical cancer in a large patient sample, examining cl
Autor:
Veronika Soukupova, Martin Skala, Vladislav Třeška, Radana Vrzáková, Jiří Dostál, Vladimír Přibáň, Tomáš Svoboda, Ondřej Hes, Radek Kucera, Kristýna Procházková, Josef Vodicka, Petr Hosek, Jana Horová, Jakub Šebek, Jindřich Fínek
Purpose: Hormonal receptor (HR) status is one of the key factors when determining the treatment of breast cancer. Even though HR conversion is one of the most researched topics recently, most of the previous studies include only the results of biopsi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fba82fd37745755c9f1a62d1a8d32767
https://doi.org/10.21203/rs.3.rs-517927/v1
https://doi.org/10.21203/rs.3.rs-517927/v1
Autor:
Igor Kiss, Tomáš Büchler, Jindřich Fínek, Pavel Dundr, Radoslav Matěj, Michal Michal, Luboš Petruželka, Bohuslav Melichar
Publikováno v:
Klinicka Onkologie. 33
BACKGROUND Tropomyosin receptor kinase inhibitors (TRKi) have been shown to produce a dramatic and long-lasting effect on tumours harbouring fusions of neurotrophic receptor tyrosine kinase (NTRK) genes. Due to the low incidence of these molecular ab